Women's oncology market will reach $110B by 2030 across therapeutics, diagnostics and care delivery
Female-specific oncology is expected to grow from about $65 billion to $75 billion today to reach $100 billion to $110 billion in 2030. This growth will be derived from areas such as therapeutics, devices and diagnostics and care delivery.
We haven't written up this one. Fierce Healthcare has the full story — the link below goes straight to it.